Introduction to Behavioral Neuroscience · Psychopharmacology
Basic Principles of Pharmacology
On this page 9 sections
In 30 seconds
Psychopharmacology is the study of how drugs act on the nervous system to change behavior, mood, and cognition. Before examining specific psychiatric medications or drugs of abuse, master the general rules that apply to every drug: how it reaches the brain (pharmacokinetics What the body does to a drug: absorption, distribution, metabolism, excretion. Full entry →), what it does at its target (pharmacodynamics What a drug does to the body: binding and receptor effects. Full entry →), and how the body changes with repeated use (tolerance Reduced effect of a drug with repeated use. Full entry → and dependence).
Two questions organize the whole topic: What does the body do to the drug? (absorption, distribution, metabolism, excretion) and what does the drug do to the body? (binding receptors, altering signaling, producing effects). Almost everything in the next two topics is these questions applied to specific molecules.
Why this matters
Every psychoactive drug — from caffeine to SSRIs and opioids — obeys the same rules. They explain why a drug on an empty stomach works faster, why some drugs never reach the brain, why the same dose affects people differently, why drugs lose effect over time, and why some have a narrow margin between helpful and harmful doses. For clinical fields they are the foundation of safe prescribing and patient education; for neuroscience they are tools for probing which transmitters and receptors drive behavior.
The college version
Core Concepts
Pharmacokinetics: what the body does to the drug
Absorption depends on the route. Oral drugs must survive the digestive tract and pass through the liver before reaching circulation — the first-pass effect — which can destroy much of the dose. Intravenous injection bypasses absorption; inhalation reaches the blood quickly; transdermal patches deliver slowly. Distribution carries the drug through the bloodstream, but the blood–brain barrier (BBB) Tight-junction capillary barrier that restricts which molecules enter the brain. Full entry → blocks many molecules from the brain. Metabolism — mostly in the liver via cytochrome P450 enzymes — converts drugs into water-soluble forms for excretion by the kidneys. half-life Time for drug concentration to fall by half. Full entry → (time for concentration to fall by half) determines dosing frequency.
The blood–brain barrier: the brain's bouncer
The BBB is formed by tight junctions between capillary endothelial cells plus supporting cells (astrocytes, pericytes). It blocks large or water-soluble molecules, while small, lipid-soluble ones pass by diffusion — which is why most psychoactive drugs are designed to be lipophilic. The barrier also actively pumps some drugs out of the brain via transporters such as P-glycoprotein. A drug that works in a test tube may fail in the brain simply because it never arrives.
Pharmacodynamics: what the drug does to the body
Most psychoactive drugs act at receptors — neuronal proteins that normally bind endogenous signaling molecules (ligands) such as neurotransmitters. Two properties matter most. affinity How tightly a drug binds its receptor. Full entry → is how tightly the drug binds; efficacy How strongly a bound drug changes receptor activity. Full entry → is how strongly it changes receptor activity once bound. A full agonist produces a strong response, mimicking the natural ligand; a partial agonist produces a weaker response; an antagonist blocks the natural ligand; an inverse agonist does the opposite of the natural ligand. Drugs can also act indirectly — blocking reuptake transporters, inhibiting degrading enzymes, or altering release — rather than binding the receptor itself.
Dose–response relationships
As dose increases, effect grows until a plateau. The ED50 is the dose producing a specified effect in 50% of a population; the LD50 is the dose lethal to 50%. Their ratio, the therapeutic index Ratio of LD50 to ED50; the safety margin. Full entry →, is the safety margin: small index = narrow window between therapeutic and toxic. Potency (dose needed for an effect) is often confused with efficacy (maximum effect achievable) — a highly potent drug is not necessarily more effective.
Tolerance, dependence, and withdrawal
With repeated use, the body adapts. Metabolic tolerance means the liver processes the drug faster; pharmacodynamic tolerance means receptors or signaling adjust (desensitization, downregulation), so the same dose has less effect. Dependence is the adapted state in which normal function requires the drug; stopping abruptly produces withdrawal. Cross-tolerance extends to other drugs in the same class. These adaptations explain why chronic users need higher doses and why withdrawal mirrors the acute effect.
How It Works / Step-by-Step Process
Journey of an oral psychoactive drug:
- The pill is swallowed and dissolves; the drug is absorbed across the gut into the portal blood.
- The blood passes through the liver, where first-pass metabolism destroys a portion of the dose (the rest reaches general circulation).
- The drug circulates; being small and lipid-soluble, it crosses the BBB into the brain.
- At the synapse, it binds its receptor — activating it (agonist), blocking it (antagonist), or acting indirectly (e.g., blocking a reuptake transporter).
- Receptors transduce the signal; neuronal firing and downstream signaling change; behavior, mood, or cognition shifts.
- Meanwhile the liver metabolizes the drug into water-soluble forms and the kidneys excrete them; after one half-life, half the drug is gone — the cycle repeats at the next dose.
Common Confusions
| Common Confusion | With | Difference |
|---|---|---|
| Pharmacokinetics and pharmacodynamics are the same. | Two complementary processes | Kinetics = what the body does to the drug; dynamics = what the drug does to the body. |
| Potency and efficacy are the same. | Distinct drug properties | Potency = dose needed; efficacy = maximum effect achievable. A potent drug can have low efficacy. |
| High affinity means a big response. | Affinity vs efficacy | Binding strength is separate from response; an antagonist can have high affinity and zero efficacy. |
| The brain is easy for drugs to reach. | The blood–brain barrier | The BBB excludes most large and water-soluble molecules; psychoactive drugs are lipid-soluble by design. |
| Tolerance and addiction are the same. | Tolerance vs dependence | Tolerance is reduced effect with repeated use; dependence is the adapted state where stopping causes withdrawal. |
| More drug always means more effect. | The dose–response plateau | Effects plateau at receptor saturation; beyond that, higher doses add risk, not benefit. |

Eli explains
The same idea, in plain words
Explain it like I’m 10
A drug is like a key, and a receptor is like a lock on a brain cell. Some keys fit and turn the lock (agonists), some fit but only turn halfway (partial agonists), and some jam the lock so the real key can't be used (antagonists). The drug also has to travel from your stomach to your brain, get past the brain's "bouncer" (the blood–brain barrier), and get cleaned up by your liver — and with repeated use the brain adjusts, so the same dose stops working as well.
Worked example
Two drugs treat the same condition. Drug A has high affinity, high efficacy, a long half-life, and a therapeutic index of 100. Drug B has moderate affinity, equal efficacy, a short half-life, and a therapeutic index of 2. Drug A acts at low doses, once a day, and a tenfold overdose is survivable; Drug B must be taken several times a day and a small dosing error can be lethal. A clinician weighs these pharmacokinetic and pharmacodynamic differences — not just "which drug is stronger" — when choosing. "Potent" (small dose needed) and "safe" (wide therapeutic index) are separate virtues.
Key takeaways
- Pharmacokinetics = what the body does to the drug (absorption, distribution, metabolism, excretion); pharmacodynamics = what the drug does to the body (receptor effects).
- BBB: only small, lipid-soluble molecules pass readily; efflux transporters actively remove some drugs.
- Agonist vs antagonist: agonist activates; antagonist blocks; partial agonist activates weakly; inverse agonist does the opposite of the natural ligand.
- Affinity ≠ efficacy: binding strength vs response strength.
- Therapeutic index = LD50/ED50: narrow index = small safety margin.
- First-pass effect: oral drugs lose a fraction of the dose in the liver before reaching circulation.
- Tolerance (metabolic and pharmacodynamic) → dependence → withdrawal; cross-tolerance within drug classes.
Check yourself
6 review questions from the chapter. Try each one, then open the answer.
Distinguish pharmacokinetics from pharmacodynamics, and give one example of each.
Show answer
Pharmacokinetics: what the body does to the drug (e.g., liver metabolism). Pharmacodynamics: what the drug does to the body (e.g., blocking a receptor).
Why can't most drugs simply diffuse into the brain? Name two properties that determine whether a molecule crosses the BBB.
Show answer
The blood–brain barrier's tight junctions exclude most large and water-soluble molecules. Crossing depends mainly on small size and lipid solubility; efflux transporters can also pump drugs out of the brain.
A drug binds a receptor tightly but produces no response and blocks the natural ligand. What is it? How does it differ from a partial agonist?
Show answer
An antagonist: it binds (high affinity) but produces no activation (zero efficacy) and blocks the natural ligand. A partial agonist binds and produces a weaker-than-full response rather than none.
Explain why a narrow therapeutic index makes a drug risky.
Show answer
A narrow therapeutic index (LD50/ED50 close to 1) means the toxic dose is close to the effective dose — small dosing errors or individual variation can turn a helpful dose into a harmful one.
Describe metabolic tolerance versus pharmacodynamic tolerance.
Show answer
Metabolic tolerance: the liver metabolizes the drug faster (e.g., enzyme induction). Pharmacodynamic tolerance: receptors or downstream signaling adapt (desensitization/downregulation), so the same dose produces less effect.
What is the first-pass effect and why does it matter for oral drugs?
Show answer
After gut absorption, blood passes through the liver, which metabolizes a fraction of the dose before circulation, reducing the amount reaching the brain.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- pharmacokinetics
- What the body does to a drug: absorption, distribution, metabolism, excretion.
- pharmacodynamics
- What a drug does to the body: binding and receptor effects.
- blood–brain barrier (BBB)
- Tight-junction capillary barrier that restricts which molecules enter the brain.
- agonist / antagonist
- Agonist activates a receptor; antagonist blocks it.
- affinity
- How tightly a drug binds its receptor.
- efficacy
- How strongly a bound drug changes receptor activity.
- therapeutic index
- Ratio of LD50 to ED50; the safety margin.
- half-life
- Time for drug concentration to fall by half.
- tolerance
- Reduced effect of a drug with repeated use.
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.

